ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Search by Abstract Number Results

  • Abstract Number: 911 • 2019 ACR/ARP Annual Meeting

    Perfusion in Bone Marrow Lesions Assessed on Dynamic Contrast-enhanced MRI and Its Association with Pain in Knee Osteoarthritis: A Cross-sectional Study

    Cecilie Daugaard1, Robert Riis 2, Elisabeth Bandak 3, Janus Nybing 4, Stine Hangaard 3, Henrik Gudbergsen 3, Marius Henriksen 3, Henning Bliddal 3 and Mikael Boesen 4, 1The Parker Institute, Copenhagen University Hospital Bispebjerg-Frederiksberg, Copenhagen, Denmark, Frederiksberg, Sjelland, Denmark, 2Dept. of Radiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark, Copenhagen, Denmark, 3The Parker Institute, Copenhagen University Hospital Bispebjerg-Frederiksberg, Copenhagen, Denmark, Copenhagen, Denmark, 4Dept. of Radiology, Copenhagen University Hospital Bispebjerg-Frederiksberg, Copenhagen, Denmark, Copenhagen, Denmark

    Background/Purpose: In osteoarthritis (OA) structural changes are only weakly associated with pain. The reason for this discrepancy remains unknown and the exact cause of knee…
  • Abstract Number: 911 • 2018 ACR/ARHP Annual Meeting

    Demographic and Clinical Characteristics Reflect Differences in Osteoarthritis Phenotypes of the Lumbar Spine: The Johnston County Osteoarthritis Project

    Adam P. Goode1, Becki Cleveland2, Todd Schwartz3, Steven Z. George4, Virginia B. Kraus5, Richard Gracely6, Jun Chen4, Joanne M. Jordan7 and Yvonne M. Golightly8, 1O, Duke University, Durham, NC, 2University of North Carolina at Chapel Hill, Chapel Hill, NC, 3Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, 4Department of Orthopedic Surgery, Duke University, Durham, NC, 5Duke Molecular Physiology Institute, Duke University, Durham, NC, 6University of North Carolina, Chapel Hill, North Carolina, Chapel Hill, NC, 7Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 8Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC

    Background/Purpose: Spine osteoarthritis (OA) has been defined by the presence of: 1) disc space narrowing (DSN) and vertebral osteophytes (OST), or 2) facet joint OA…
  • Abstract Number: 911 • 2017 ACR/ARHP Annual Meeting

    How Well Do Rheumatology Fellows Manage Acute Infusion Reactions?  a Pilot Curricular Intervention

    Jason Weiner1, Amanda M. Eudy2 and Lisa Criscione-Schreiber3, 1Department of Medicine, Division of Rheumatology and Immunology, Duke University Medical Center, Durham, NC, 2Duke University Medical Center, Chapel Hill, NC, 3Internal Medicine, Duke University Medical Center, Durham, NC

    Background/Purpose: Infusible DMARDs are commonly prescribed in rheumatology and other fields. There are no published formal educational curricula rheumatology fellowship programs can use to teach…
  • Abstract Number: 911 • 2016 ACR/ARHP Annual Meeting

    Efficacy and Safety of Tocilizumab in Patients with Giant Cell Arteritis: Primary and Secondary Outcomes from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial

    John H. Stone1, Katie Tuckwell2, Sophie Dimonaco2, Micki Klearman3, Martin Aringer4, Daniel Blockmans5, Elisabeth Brouwer6, Maria C. Cid7, Bhaskar Dasgupta8, Juergen Rech9, Carlo Salvarani10, Robert F. Spiera11, Sebastian H. Unizony1, Neil Collinson2 and the GiACTA Investigators, 1Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA, 2Roche Products Ltd., Welwyn Garden City, United Kingdom, 3Genentech, South San Francisco, CA, 4Abteilung für Rheumatologie, Dresden, Germany, 5General Internal Medicine, University Hospitals Gasthuisberg, Leuven, Belgium, 6Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 7Vasculitis Research Unit. Department of Autoimmune Diseases, Hospital Clínic. University of Barcelona. IDIBAPS, Barcelona, Spain, 8Rheumatology, Southend University Hospital NHS Foundation Trust, Westcliff-on-Sea, United Kingdom, 9Friedrich-Alexander-University Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany, 10Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy, 11Hospital for Special Surgery, Cornell, New York, NY

    Background/Purpose: The efficacy and safety of tocilizumab (TCZ), an IL-6 receptor-alpha inhibitor, was evaluated in patients with giant cell arteritis (GCA) in GiACTA, a randomized,…
  • Abstract Number: 911 • 2015 ACR/ARHP Annual Meeting

    Patients with Rheumatoid Arthritis Are at Increased Risk of Both Ischemic and Non-Ischemic Heart Failure

    Ängla Mantel1, Marie Holmqvist1, Daniel Andersson2,3, Lars Lund2,3 and Johan Askling4,5, 1Dept of Medicine, Clinical Epidemiology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, 2Department of medicine, Karolinska Institutet, Cardiology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, 3Karolinska university hospital, Cardiology Unit, Karolinska University Hospital, Stockholm, Sweden, 4Rheumatology Unit, Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden, 5Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Studies among unselected patients with rheumatoid arthritis (RA) suggest increased risks of both ischemic and non-ischemic heart failure (HF). Since the risk of these…
  • Abstract Number: 911 • 2014 ACR/ARHP Annual Meeting

    Bioluminescent Imaging of Histidyl-Transfer RNA Synthetase-Induced Myositis Reveals Early-Phase Involvement of NF-Kb-Mediated Inflammation

    Nicholas A. Young1, Lai-Chu Wu1, Michael Bruss2, Wael N. Jarjour3 and Dana P. Ascherman4, 1Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 2Division of Rheumatology and Immunology, The Ohio State University Wexner Medical Center, Columbus, OH, 3Dept of Rheumatology/Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, 4Rheumatology, Miami VAMC, Miami, FL

    Background/Purpose:  The idiopathic inflammatory myopathies represent a group of autoimmune diseases that target muscle as well as extra-muscular organs, leading to significant morbidity and mortality. …
  • Abstract Number: 911 • 2013 ACR/ARHP Annual Meeting

    Neutralization Of Anti-Citrullinated Protein Antibodies – a Way To Go?

    Catia Cerqueira1, Elena Ossipova2, Monika Hansson3, Linda Mathsson4, Lars Klareskog3, Johan Rönnelid4 and Per Johan Jakobsson5, 1Medicine, Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 2Rheumatology unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 3Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 4Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden, 5Rheumatology unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: In a previous study, we have identified endogeneously citrullinated sites in fibrinogen from RA synovial tissue (Hermansson M. et al.  Proteomics Clin Appl, 2010).…
  • Abstract Number: 911 • 2012 ACR/ARHP Annual Meeting

    Race- and Sex-Specific Estimates of 10-, 20-, 30-Year, and Lifetime Risk of Diagnosed Symptomatic Knee Osteoarthritis and the Need for TKR in the US

    Elena Losina1, Meghan E. Daigle1, Sara A. Burbine1 and Jeffrey N. Katz2, 1Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 2Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: A growing body of evidence suggests that females are more likely to be diagnosed with knee osteoarthritis (OA) and that obesity increases the risk…
Search Again »

Didn't find what you were looking for? Try the Advanced Search »

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology